Literature DB >> 3789803

Plasma exchange and leukapheresis in psoriasis--no effect?

G Liedén, M Skogh.   

Abstract

Nine patients with severe or therapy-resistant psoriasis were treated by plasma exchanges or leukapheresis; one received both treatments in succession. None of the patients showed convincing signs of improvement. We therefore conclude that there is little evidence for the existence of a "psoriasis factor", the removal of which, it has been suggested, would explain the beneficial effects of dialysis. Nor is there anything to indicate that the removal of large numbers of leukocytes would bring about healing.

Entities:  

Mesh:

Year:  1986        PMID: 3789803     DOI: 10.1007/bf00455159

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  13 in total

1.  Hemodialysis in the treatment of psoriasis. A controlled trial.

Authors:  A R Nissenson; M Rapaport; A Gordon; R G Narins
Journal:  Ann Intern Med       Date:  1979-08       Impact factor: 25.391

2.  [Experience with hemodialysis in the therapy of various chronic dermatoses].

Authors:  V A Rakhmanov; N S Potekaev; M I Sorokina; E K Chilingaridi; A V Konstantinov
Journal:  Sov Med       Date:  1967-06

3.  [Treatment of a psoriasis patients with hemodialysis].

Authors:  E M Shimkus; T A Malygina; N I Kalenkovich
Journal:  Vestn Dermatol Venerol       Date:  1970-02

4.  Dialysis treatment of psoriasis.

Authors:  P C Anderson
Journal:  Arch Dermatol       Date:  1981-02

5.  Plasmapheresis in the management of psoriasis.

Authors:  R Schuster; R Lenzhofer; M Raff
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

6.  Dialysis and psoriasis.

Authors: 
Journal:  Ann Intern Med       Date:  1978-06       Impact factor: 25.391

7.  Ultrastructural damage of leukocytes procured by the Leukopak: vulnerability of leukocytes to mechanical injury.

Authors:  C Ts'ao; E A Ruder
Journal:  Transfusion       Date:  1976 Jul-Aug       Impact factor: 3.157

8.  [Peritoneal dialysis and leukopheresis in psoriasis: indications and contraindications].

Authors:  W Glinski; S Jablonska; J Imiela; J Daszynski
Journal:  Hautarzt       Date:  1985-01       Impact factor: 0.751

9.  Peritoneal dialysis for psoriasis. An uncontrolled study.

Authors:  Z J Twardowski; K D Nolph; J Rubin; P C Anderson
Journal:  Ann Intern Med       Date:  1978-03       Impact factor: 25.391

10.  The activity of polymorphonuclear leukocyte neutral proteinases and their inhibitors in patients with psoriasis treated with a continuous peritoneal dialysis.

Authors:  W Glinski; Z Zarebska; S Jabłonska; J Imiela; J Nosarzewski
Journal:  J Invest Dermatol       Date:  1980-12       Impact factor: 8.551

View more
  2 in total

Review 1.  Cytokine-based therapy in psoriasis.

Authors:  Anupam Mitra; Robyn S Fallen; Hermenio Cavalcante Lima
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

2.  Targeting IL-23: insights into the pathogenesis and the treatment of psoriasis.

Authors:  Hermenio Cavalcante Lima; Alexandra Boer Kimball
Journal:  Indian J Dermatol       Date:  2010 Apr-Jun       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.